Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting the NF-κB and TLR7 pathways in mice - 09/12/18
, Guiying Zhang b, ⁎ , Mingliang Chen c, Min Tong d, Ming Zhao b, Fang Tang e, Rong Xiao b, Haiquan Wen bBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 8 |
| Iconographies | 7 |
| Vidéos | 0 |
| Autres | 0 |
Graphical abstract |
Highlights |
• | p65 and TLR7 signaling pathways were activated in imiquimod-induced psoriasis-like dermatitis mouse model. |
• | RUT treatment improves imiquimod-induced psoriasis-like dermatitis in mice. |
• | RUT treatment suppressed imiquimod-induced activation of p65 and TLR7/MyD88/TRAF6 pathways. |
Abstract |
Psoriasis is a chronic, immune-mediated inflammatory skin disease. As psoriasis rarely occurs in nonhuman animals, the lack of an ideal animal model reflecting the histopathological and molecular immunological characteristics of psoriasis remains an urgent issue. In the present study, an imiquimod-induced psoriasis-like dermatitis mouse model was constructed under natural immune conditions and verified by evaluations of the Psoriasis Area and Severity Index (PASI) score and Baker score, H&E staining, immunohistochemical examination of the CD3 and Gr1 levels, measurement of plasmacytoid dendritic cell- (pDC) and Th17-associated cytokine levels, and evaluation of p65 phosphorylation and TLR7 expression. Moreover, rutaecarpine (RUT), the main active ingredient in the traditional Chinese medicine Wu-Zhu-Yu, could improve psoriasis-like dermatitis through effects on pDC- and Th17-associated cytokines through NF-κB and toll-like receptor 7 (TLR7) signaling. Taken together, the imiquimod-induced psoriasis-like dermatitis mouse model can be regarded as an ideal model for evaluating psoriasis pathogenesis and antipsoriatic drugs. We provided theoretical and experimental evidence for the clinical application of RUT in psoriasis.
Le texte complet de cet article est disponible en PDF.Abbreviations : PASI, IL, pDCs, IFN-α, Th, DXM, IHC, TLR7
Key words : Psoriasis-like dermatitis, Rutaecarpine, Cytokines, NF-κB signaling, TLR7 signaling pathway
Plan
Vol 109
P. 1876-1883 - janvier 2019 Retour au numéro
Article précédent
- α, β-Amyrin, a pentacyclic triterpenoid from Protium heptaphyllum suppresses adipocyte differentiation accompanied by down regulation of PPARγ and C/EBPα in 3T3-L1 cells
- Karina Moura de Melo, Francisca Tuelly Bandeira de Oliveira, Rose Anny Costa Silva, Ana Luiza Gomes Quinderé, José Delano Barreto Marinho Filho, Ana Jérsia Araújo, Eanes Delgado Barros Pereira, Adonias Almeida Carvalho, Mariana Helena Chaves, Vietla Satyanarayana Rao, Flávia Almeida Santos
- Nox1/4 dual inhibitor GKT137831 attenuates hypertensive cardiac remodelling associating with the inhibition of ADAM17-dependent proinflammatory cytokines-induced signalling pathways in the rats with abdominal artery constriction
- Si-yu Zeng, Li Yang, Qiu-jiang Yan, Ling Gao, Hui-qin Lu, Peng-ke Yan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?